Arca
Skip to content
Tools
Tools

Access Afp Immunoassay System

Kit, test, alpha-fetoprotein for neural tube defects. PMA P980041, from Beckman Coulter, Inc. (Brea, CA). Product code LOK, class 3.

As of Nov 18, 2026, P980041 is an FDA PMA held by Beckman Coulter, Inc., approved on Feb 8, 1999 after 115 days, with no recalls tied to it in FDA's recall database.

  • Review time: 115 days
  • Supplements: 47
  • Recalls: 0
  • Cited as a predicate by: 1 device

What FDA approved

FDA's approval order statement

Approval for the Access(R) AFP Reagents on the Access(R) Immunoassay Analyzer. The Access(R) AFP assay is a paramagnetic particle, chemiluminescent immunoassay for use with the Access(R) Immunoassay System for the quantitative determination fo alpha-fetoprotein (AFP) in: 1)Human seru, as an aid in management of patients with non-seminomatous testicular cancer. 2) Maternal serum and amniotic fluid at 15 to 20 weeks gestation, to aid in the detection of fetal open neural tube defects (ONTD). The assay is intended for use in conjunction with other diagnostic tools such as ultrasound and amniography.

Pivotal study

The main clinical evidence FDA relied on, as its Summary of Safety and Effectiveness describes it
Design
Multicenter, retrospective study of archived maternal serum and amniotic fluid specimens vs. confirmed pregnancy outcomes
Enrolled
3,737
Where
3 sites, US, Canada
Primary endpoint
Clinical sensitivity and specificity for detection of fetal open neural tube defects (ONTD) at 15-20 weeks gestation
Result
Maternal serum at 2.0 MoM: sensitivity 91.3% (21/23), specificity 95.4% (2421/2539); amniotic fluid at 3.0 MoM: sensitivity 100% (15/15), specificity 99.3% (715/720)

Cited as a predicate

1 later 510(k) summary names this device as a predicate

Supplements

47 supplements to this PMA; the 15 newest
Nov 3, 2025S051Labeling Change - Indications/instructions/shelf life/tradenameNormal 180 Day Track
Dec 16, 2022S050Change Design/Components/Specifications/MaterialReal-Time Process
Dec 16, 2020S049Change Design/Components/Specifications/MaterialReal-Time Process
Oct 16, 2020S048Change Design/Components/Specifications/MaterialReal-Time Process
Oct 7, 2020S047Change Design/Components/Specifications/MaterialReal-Time Process
May 28, 2020S043Process Change - Manufacturer/Sterilizer/Packager/Supplier135 Review Track For 30-Day Notice
Mar 17, 2020S046Change Design/Components/Specifications/MaterialReal-Time Process
Aug 9, 2019S045Change Design/Components/Specifications/MaterialReal-Time Process
Jul 31, 2019S044Change Design/Components/Specifications/MaterialReal-Time Process
Dec 21, 2018S041Change Design/Components/Specifications/MaterialReal-Time Process
Sep 12, 2018S040Process Change - Manufacturer/Sterilizer/Packager/Supplier30-Day Notice
Oct 24, 2017S039Process Change - Manufacturer/Sterilizer/Packager/Supplier30-Day Notice
Jul 7, 2017S037Process Change - Manufacturer/Sterilizer/Packager/Supplier30-Day Notice
Jun 16, 2017S036Change Design/Components/Specifications/MaterialReal-Time Process
Feb 14, 2017S035Process Change - Manufacturer/Sterilizer/Packager/Supplier30-Day Notice

Record

Type
Original PMA
Received
Oct 16, 1998
Review panel
Immunology

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.